Aquestive Therapeutics AQST
NASDAQ AQST
$3.58 +0.06 (+1.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Aquestive Therapeutics (AQST) Price to FCF (2023)

Updated

Aquestive Therapeutics' Price to FCF was 17.10 in Q3 2023, up 86.0% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Price to FCF (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Aquestive Therapeutics 442.42 Mn 21.68 Mn 3.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 17.10
Jun 30, 2023 9.19
Mar 31, 2023 5.08
API Access

Aquestive Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=AQST&period=max&api_key=YOUR_API_KEY